Philippe Ayala leads the team that builds CAS Newton, CAS’s AI platform for scientific discovery. Before joining CAS, he led cancer drug discovery teams at BioNumerik Pharmaceuticals, contributing to two drugs that advanced to registration trials. He has also spent time in academia, developing methods for high-performance electronic structure calculations under Prof. H. B. Schlegel at Wayne State University and Prof. Gustavo Scuseria at Rice University. Philippe holds Dipl. Ing. From Ecole Supérieure de Chimie Physique Électronique de Lyon and a Ph.D. in quantum chemistry from Wayne State University.
